Hollencrest Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.45K Sell
14
-352
-96% -$137K ﹤0.01% 831
2025
Q1
$159K Sell
366
-1,049
-74% -$456K 0.01% 295
2024
Q4
$522K Buy
1,415
+4
+0.3% +$1.48K 0.02% 186
2024
Q3
$734K Sell
1,411
-177
-11% -$92K 0.03% 171
2024
Q2
$860K Buy
1,588
+3
+0.2% +$1.63K 0.04% 154
2024
Q1
$822K Buy
1,585
+48
+3% +$24.9K 0.04% 156
2023
Q4
$725K Sell
1,537
-42
-3% -$19.8K 0.07% 154
2023
Q3
$688K Buy
1,579
+3
+0.2% +$1.31K 0.08% 137
2023
Q2
$700K Sell
1,576
-11
-0.7% -$4.89K 0.07% 143
2023
Q1
$730K Buy
1,587
+3
+0.2% +$1.38K 0.08% 134
2022
Q4
$813K Buy
1,584
+528
+50% +$271K 0.1% 112
2022
Q3
$480K Sell
1,056
-1,267
-55% -$576K 0.06% 157
2022
Q2
$1.12M Sell
2,323
-198
-8% -$95.5K 0.13% 89
2022
Q1
$1.24M Buy
2,521
+185
+8% +$90.8K 0.11% 99
2021
Q4
$1.08M Buy
2,336
+2
+0.1% +$926 0.09% 117
2021
Q3
$870K Buy
2,334
+770
+49% +$287K 0.08% 132
2021
Q2
$598K Sell
1,564
-780
-33% -$298K 0.05% 175
2021
Q1
$841K Buy
2,344
+979
+72% +$351K 0.08% 132
2020
Q4
$438K Hold
1,365
0.05% 190
2020
Q3
$367K Buy
1,365
+32
+2% +$8.6K 0.04% 202
2020
Q2
$350K Sell
1,333
-4
-0.3% -$1.05K 0.05% 190
2020
Q1
$303K Sell
1,337
-292
-18% -$66.2K 0.04% 194
2019
Q4
$492K Buy
1,629
+135
+9% +$40.8K 0.06% 177
2019
Q3
$359K Buy
1,494
+47
+3% +$11.3K 0.04% 192
2019
Q2
$408K Hold
1,447
0.05% 185
2019
Q1
$416K Buy
1,447
+55
+4% +$15.8K 0.06% 178
2018
Q4
$366K Sell
1,392
-55
-4% -$14.5K 0.05% 179
2018
Q3
$416K Sell
1,447
-72
-5% -$20.7K 0.06% 178
2018
Q2
$361K Sell
1,519
-56
-4% -$13.3K 0.05% 192
2018
Q1
$346K Buy
1,575
+112
+8% +$24.6K 0.05% 197
2017
Q4
$329K Hold
1,463
0.04% 209
2017
Q3
$278K Buy
1,463
+142
+11% +$27K 0.04% 229
2017
Q2
$249K Sell
1,321
-142
-10% -$26.8K 0.04% 236
2017
Q1
$242K Buy
+1,463
New +$242K 0.04% 286